Bendamustine
CAS 16506-27-7
In Stock
Bendamustine
Cat. No. ANT-BND-000CAS 16506-27-7In Stock
Technical Data
Cat. No.ANT-BND-000
CAS16506-27-7
Mol. FormulaC16H21Cl2N3O2 : HCl
Mol. Weight358.269 g/mol
IUPAC4-[5-[bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoic acid
SMILESCN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCC(=O)O
InChIInChI=1S/C16H21Cl2N3O2/c1-20-14-6-5-12(21(9-7-17)10-8-18)11-13(14)19-15(20)3-2-4-16(22)23/h5-6,11H,2-4,7-10H2,1H3,(H,22,23)
InChI KeyYTKUWDBFDASYHO-UHFFFAOYSA-N
Purity99%
Description
Overview
Bendamustine, sold under the brand name Treanda among others, is a chemotherapy medication used in the treatment of chronic lymphocytic leukemia, multiple myeloma, and non-Hodgkin's lymphoma. It is given by injection into a vein
Anant Labs manufacture and furnish high quality Bendamustine impurities for global markets. Our Bendamustine EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Synonyms
5-[Bis(2-chloroethyl)-amino]-1-methyl-1H-benzimidazole-2-butanoic Acid4-(5-(Bis(2-chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoic AcidBendamustine (USP)Bendamustine16506-27-7BendamustinaBendamustinum4-[5-[bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoic acidDTXSID20468889266D9P3PQ
